RESEARCH / DISCOVERY
← Back to the library

[The role of dopaminagonists in the treatment of Parkinson's disease].

[The role of dopaminagonists in the treatment of Parkinson's disease].

Read the original publication

A plain-language reading has not been prepared for this paper yet.

Original abstract

Dopamine agonists play an important role in the treatment of early Parkinson's disease, either as monotherapy or in combination with levodopa. Initial treatment with dopamine agonists has been found to postpone or prevent from motor fluctuations and dyskinesias. Dopamine agonists have also been shown to be significantly effective in the treatment of motor oscillations and dyskinesias related to chronic levodopa treatment. The "new" dopaminagonists pergolide, cabergoline, ropinirole and pramipexole tend to be more effective than bromocriptine. Due to side-effects dopamine agonists are mainly used in subjects younger than 70 to 75 years.

Explore another example or bring your own paper

Pasted text and PDF extraction stay on this computer. The local guide explains terms and surfaces passages; rewriting requires a configured local model. Scanned PDFs need OCR first.

RECORD & PROVENANCE